查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018711

辐射剂量监测市场：按产品类型、应用和最终用户划分 - 2026-2032年全球市场预测

Radiation Dose Monitoring Market by Product Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，辐射剂量监测市场价值将达到 4.3044 亿美元，到 2026 年将成长至 4.9046 亿美元，到 2032 年将达到 11.5648 亿美元，复合年增长率为 15.16%。

主要市场统计数据
基准年 2025 4.3044亿美元
预计年份：2026年 4.9046亿美元
预测年份 2032 1,156,480,000 美元
复合年增长率 (%) 15.16%

策略性实施，确立辐射剂量监测在临床路径、技术法规和病人安全优先事项的关键意义。

辐射剂量监测已从一项小众的合规活动转变为临床品质、病人安全和企业数据策略的核心支柱。诊断影像的日益复杂、介入手术的激增以及监管力度的加强，使得即时和回顾性剂量资讯已成为必需品，而不再仅仅是可选项。临床团队现在期望整合的工作流程能够提供情境化的剂量警报、自动文件记录和分析回馈循环，以帮助优化各种检查方式的方案。

人工智慧驱动的分析、云端策略、更严格的监管以及以患者为中心的品质保证的需求，这些变革正在重新定义辐射剂量监测。

辐射剂量监测领域正经历着一场变革，其驱动力包括技术的快速成熟、不断变化的监管要求以及不断涌现的临床需求。人工智慧 (AI) 和机器学习正被整合到剂量分析中，从而实现异常值识别、方案偏差预测以及近乎即时的参数调整建议。因此，剂量监测解决方案正从被动的资料储存库演变为能够影响临床操作人员行为和方案选择的主动决策工具。

评估 2025 年美国关税变化对全球供应链采购韧性和剂量监测临床技术部署的累积影响。

2025年实施的关税措施对辐射剂量监测技术领域的製造商、经销商和医疗保健机构产生了复杂而深远的后续影响。供应商正在调整采购、零件替代和物流策略，以应对成本压力并维持生产连续性，供应链的韧性正面临考验。对于许多企业而言，供应商多元化和探索近岸外包变得越来越重要，因为依赖单一来源的零件会加剧其对贸易政策变化的脆弱性。

清晰的细分市场分析：展示产品类型、临床应用和最终用户特征如何决定采购行为、部署管道和服务期望。

对市场区隔的精准理解揭示了每种产品类型、临床应用和最终用户环境的不同需求，这有助于产品设计和商业化策略的发展。就产品类型而言，市场可分为设备与服务两大类。设备客户会根据处理能力、空间限制和所执行手术的配置来权衡固定式设备和可携式之间的优缺点。而服务客户则会在持续维护合约（以确保运转率和符合法规要求）与咨询专业知识之间进行权衡。

区域趋势：本节阐明了推动剂量监测技术、报销途径和采用模式的因素在美洲、欧洲、中东和非洲以及亚太地区有何不同。

区域趋势对辐射剂量监测技术的应用和实施有显着影响，各主要区域之间存在显着差异。在美洲，法律规范和报销环境推动了集中式分析与现场优化相结合的发展，医疗系统也经常寻求能够跨医院网路扩展的企业级部署方案。这催生了对能够提供多站点管治、标准化报告以及与现有电子健康记录和品质註册系统整合的解决方案的需求。

企业策略和竞争动态塑造了辐射剂量监测整个价值链中的创新伙伴关係、服务模式和监管合规性。

剂量监测生态系中的企业行为呈现产品创新、策略伙伴关係与服务多元化融合的趋势。领先的供应商意识到，分析、报告和生命週期服务正日益成为衡量客户价值的关键因素，因此正加大对软体能力的投入，以完善其硬体产品组合。与临床网路、学术机构和第三方分析提供者建立伙伴关係十分普遍，这有助于加速检验、扩展基准测试资料集，并共同开发整合到工作流程中的决策支援模组。

为产业领导者提供切实可行的建议，以加快剂量监测投资的采用、加强合规性并从中提取临床营运价值。

致力于加速剂量监测技术应用并提升其有效性的行业领导者应立即采取谨慎措施，确保技术选择与临床和营运重点保持一致。首先，投资于支援标准化资料交换并与电子健康记录和影像系统无缝整合的互通平台。这将减少工作流程中的摩擦，并改善企业管治。其次，优先考虑模组化架构和软体定义功能，以实现分阶段升级，并减少对可能中断营运的大规模设备更换週期的依赖。

调查方法，描述了一种严格的混合方法，结合了相关人员访谈、设备审核、监管审查和技术检验协议。

严谨的混合方法研究途径是获取辐射剂量监测可靠见解的基础，它将与相关人员的定性对话与技术和法规分析相结合。主要资讯来源包括对临床负责人、医学物理学家、放射技师和采购负责人的结构化访谈，透过这些访谈了解实际操作、实施障碍和理想解决方案的特征。除了这些对话之外，还进行仪器和工作流程审核，以观察资料收集点、整合点以及方案协调的机会。

结论：本报告整合了策略性关键要点和可操作的见解，旨在帮助相关人员提高病患安全、工作流程效率和技术整合水准。

技术、临床和商业性观点的整合凸显了一个明确的需求：辐射剂量监测必须从孤立的合规机制转变为支持更安全、更有效率医疗保健的综合临床智慧。儘管分析技术和云端基础设施的进步使这一转变成为可能，但其成功取决于对互通性、管治和证据生成的认真考虑。优先考虑模组化架构、灵活经营模式和稳健服务伙伴关係关係的组织将更有能力长期维持其能力。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 辐射剂量监测市场：依产品类型划分

  • 装置
    • 固定设备
    • 携带式设备
  • 服务
    • 咨询服务
    • 维护服务

第九章：辐射剂量监测市场：依应用领域划分

  • 诊断影像
    • 电脑断层扫描
    • 磁振造影
    • 超音波
    • X射线
  • 介入放射学
    • 心臟介入
    • 介入神经放射学
    • 血管介入
  • 核子医学
    • 正子断层扫描
    • 单光子发射电脑断层扫描
  • 放射治疗
    • 近距离放射治疗
    • 远距放射线治疗

第十章 辐射剂量监测市场：依最终用户划分

  • 学术机构
  • 诊所
  • 诊断中心
  • 医院

第十一章：辐射剂量监测市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章：辐射剂量监测市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章：辐射剂量监测市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章：美国辐射剂量监测市场

第十五章：中国辐射剂量监测市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agfa-Gevaert Group NV
  • Bayer AG
  • Bracco Imaging SpA
  • Canon Medical Systems Corporation
  • Fluke Biomedical
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Guerbet SA
  • Koninklijke Philips NV
  • Landauer, Inc.
  • Ludlum Measurements, Inc.
  • Medtronic plc
  • Mirion Technologies, Inc.
  • Novarad Corporation
  • PACSHealth, LLC
  • Qaelum NV
  • Radiation Detection Company（RADEC）
  • Sectra AB
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Unfors Raysafe AB
Product Code: MRR-AD36CD8983FB

The Radiation Dose Monitoring Market was valued at USD 430.44 million in 2025 and is projected to grow to USD 490.46 million in 2026, with a CAGR of 15.16%, reaching USD 1,156.48 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 430.44 million
Estimated Year [2026] USD 490.46 million
Forecast Year [2032] USD 1,156.48 million
CAGR (%) 15.16%

A strategic introduction establishing the critical importance of radiation dose monitoring across clinical pathways technology regulations and patient safety priorities

Radiation dose monitoring has moved from a niche compliance activity into a central pillar of clinical quality, patient safety, and enterprise data strategy. Advances in imaging complexity, the proliferation of interventional procedures, and heightened regulatory scrutiny have combined to make real-time and retrospective dose intelligence an operational necessity rather than an optional capability. Clinical teams now expect integrated workflows that provide context-sensitive dose alerts, automated documentation, and analytic feedback loops that inform protocol optimization across modalities.

In parallel, health systems and diagnostic service providers are prioritizing technologies that reduce variability, document regulatory adherence, and support value-based care imperatives. This has elevated expectations for interoperability, as dose monitoring must exchange structured information with electronic medical records, picture archiving and communication systems, and quality registries. Consequently, decisions about procurement, deployment, and service models are increasingly influenced by factors beyond raw device performance; considerations such as software lifecycle management, data governance, and vendor support frameworks are now central to adoption discussions.

Taken together, these forces are reshaping the conversation about dose monitoring: stakeholders demand systems that are not only accurate and reliable, but also demonstrably sustainable within constrained capital and operational budgets. For clinical leaders and technology planners, the imperative is to evaluate capabilities through the lenses of clinical impact, workflow integration, and long-term maintainability, ensuring that investments deliver measurable improvements in safety and efficiency.

Transformational shifts redefining radiation dose monitoring through AI enabled analytics cloud strategies regulatory tightening and patient centric quality imperatives

The landscape of radiation dose monitoring is undergoing transformative shifts driven by rapid technological maturation, shifting regulatory expectations, and new clinical imperatives. Artificial intelligence and machine learning are being embedded into dose analytics to identify outliers, predict protocol deviations, and recommend parameter adjustments in near real time. As a result, dose monitoring solutions are evolving from passive repositories into active decision-support tools that can influence operator behavior and protocol selection at the point of care.

Concurrently, cloud-native architectures and federated data approaches are enabling broader aggregation and benchmarking of dose metrics across facilities while preserving data privacy. This shift toward centralized analytics paired with distributed collection points permits longitudinal analyses that were previously impractical, and it supports enterprise-level governance and continuous improvement programs. Moreover, there is a discernible move toward modular, API-driven ecosystems that favor interoperability and incremental modernization rather than wholesale equipment replacement.

On the regulatory front, agencies are emphasizing traceability, documentation, and patient communication, which compels organizations to embed dose monitoring into clinical quality frameworks. Patient expectations are also changing: informed patients and referring clinicians increasingly request transparency about radiation exposure and comparative safety profiles. Taken together, these trends create an environment where technological innovation, data architecture, and regulatory compliance intersect to drive widespread adoption and more sophisticated use cases for dose monitoring technologies.

Assessing cumulative effects of 2025 United States tariff shifts on global supply chains procurement resilience and clinical technology adoption for dose monitoring

Tariff measures enacted in 2025 have created a complex set of downstream implications for manufacturers, distributors, and healthcare providers involved in radiation dose monitoring technologies. Supply chain elasticity has been tested as vendors adapt sourcing, component substitution, and logistics strategies to maintain manufacturing continuity while managing cost pressures. For many organizations this has elevated the importance of supplier diversification and nearshoring considerations, as reliance on single-source components can amplify vulnerability to trade policy volatility.

Procurement teams and clinical technology planners are responding by reassessing total cost of ownership and service models, with a stronger focus on maintenance contracts, spare-part availability, and remote service capabilities that can mitigate on-site constraints. In addition, extended lead times for certain components have accelerated the adoption of software-centric solutions and retrofit pathways that reduce dependence on new hardware procurement. Consequently, organizations are prioritizing interoperability and upgradeability to maximize lifespan and functional value of installed systems.

As stakeholders adapt, transparency and scenario planning have become important governance practices. Health systems are instituting contingency protocols and stock management approaches to preserve clinical continuity. Vendors that demonstrate resilient supply strategies, clear aftermarket support, and options for phased upgrades are gaining higher consideration in procurement processes. Ultimately, the tariff environment in 2025 has underscored the strategic value of flexible acquisition models and durable service partnerships for sustaining dose monitoring capabilities under shifting trade dynamics.

Segment driven clarity demonstrating how product types clinical applications and end-user characteristics determine procurement behaviors adoption pathways and service expectations

A nuanced understanding of market segments uncovers differentiated needs across product types, clinical applications, and end-user settings, which in turn informs product design and commercialization strategies. When considering product types, the landscape bifurcates into equipment and services. Equipment customers evaluate trade-offs between fixed installations and portable units based on throughput, space constraints, and procedure mix, while services customers weigh consulting expertise against ongoing maintenance commitments that sustain uptime and regulatory compliance.

Application-driven demand reflects modality-specific requirements and clinical complexity. Diagnostic imaging use cases span computed tomography, magnetic resonance imaging, ultrasound, and conventional X-ray, each presenting unique dose measurement, tracking, and reporting challenges. Interventional radiology brings distinct imperatives across cardiac, neuro, and vascular interventions where fluoroscopy time and cumulative exposure must be managed dynamically. Nuclear medicine workflows involving positron emission tomography and single photon emission computed tomography demand specialized dosimetry considerations, and radiotherapy applications such as brachytherapy and external beam treatments require tightly integrated dose verification and documentation protocols.

End-user profiles-academic institutes, clinics, diagnostic centers, and hospitals-shape procurement behavior, budget cycles, and support expectations. Academic centers tend to emphasize research extensibility and analytics sophistication, while clinics and diagnostic centers prioritize compact footprint and streamlined workflows. Hospitals demand enterprise-class interoperability, robust service guarantees, and scalable governance mechanisms. Recognizing these distinctions enables product roadmaps and commercial approaches to be tailored to the operational realities of each segment, thereby improving adoption likelihood and clinical impact.

Regional dynamics revealing how Americas Europe Middle East & Africa and Asia-Pacific diverge in adoption drivers reimbursement pathways and deployment models for dose monitoring

Regional dynamics exert powerful influence over how radiation dose monitoring technologies are adopted and implemented, with notable contrasts across major geographies. In the Americas, regulatory frameworks and reimbursement environments encourage a combination of centralized analytics and site-level optimizations, and health systems frequently pursue enterprise deployments that can scale across hospital networks. This creates demand for solutions that offer multi-site governance, standardized reporting, and integration with existing electronic health records and quality registries.

Europe, Middle East & Africa exhibits considerable heterogeneity driven by divergent regulatory regimes, infrastructure maturity, and public versus private care models. In some parts, stringent regulatory expectations and active professional societies have accelerated the adoption of dose monitoring programs, whereas in other areas resource constraints necessitate more pragmatic and phased approaches. Interoperability standards and data protection rules are central considerations, often prompting investments in secure architectures and localized data management strategies.

The Asia-Pacific region demonstrates a mix of rapid technology adoption in urban tertiary centers and pragmatic solutions for community facilities. High-volume imaging centers and leading hospitals often act as early adopters of advanced analytics and integrated dose governance, while broader system-level initiatives are gradually extending capabilities to regional facilities. Across all regions, localized regulatory nuance, capital planning cycles, and workforce availability shape deployment choices and service models, making regional strategy an essential component of any commercialization plan.

Corporate strategies and competitive dynamics shaping innovation partnerships service models and regulatory alignment across the radiation dose monitoring value chain

Corporate behavior in the dose monitoring ecosystem is characterized by a blend of product innovation, strategic partnerships, and service diversification. Leading vendors are investing in software capabilities that complement their hardware portfolios, recognizing that analytics, reporting, and lifecycle services increasingly define customer value. Partnerships with clinical networks, academic centers, and third-party analytics providers are common, enabling accelerated validation, expanded data sets for benchmarking, and co-development of workflow-embedded decision-support modules.

Commercial strategies emphasize flexible contracting and outcome-oriented services to align with customers' fiscal constraints and quality objectives. Many companies are experimenting with subscription models, managed services, and hybrid arrangements that combine capital equipment with enduring service commitments. In parallel, investments in customer success functions and remote diagnostics have become critical differentiators, as institutions value predictable uptime and proactive maintenance that minimize clinical disruption.

Regulatory diligence and standards alignment also shape corporate strategies. Vendors that demonstrate robust compliance frameworks, clear audit trails, and interoperability with mainstream health IT systems gain higher trust among procurement committees. Finally, companies that prioritize transparent evidence generation-through peer-reviewed studies, real-world performance data, and clinician endorsements-are better positioned to influence clinical guidelines and accelerate adoption across diverse healthcare settings.

Actionable recommendations for industry leaders to accelerate adoption strengthen compliance and extract clinical operational value from dose monitoring investments

Industry leaders seeking to accelerate the adoption and impact of dose monitoring should take immediate and deliberate steps to align technology choices with clinical and operational priorities. First, invest in interoperable platforms that support standardized data exchange and integrate seamlessly with electronic health records and imaging systems; this reduces workflow friction and facilitates enterprise governance. Second, prioritize modular architectures and software-defined capabilities that enable incremental upgrades and reduce dependence on disruptive capital refresh cycles.

Organizations should also formalize governance processes that link dose metrics to clinical quality programs, ensuring responsibility for monitoring, escalation, and continuous improvement. Training and change management are essential components: empowering technologists and physicians with contextualized feedback and clear escalation pathways drives behavioral change more effectively than standalone alerts. From a commercial standpoint, adopt flexible procurement structures such as outcome-based agreements or managed services to align incentives between vendors and providers.

Finally, develop a roadmap for evidence generation that includes local validation studies, peer-reviewed publications, and cross-site benchmarking. Demonstrating clinical and operational benefits builds stakeholder confidence and supports broader rollouts. By combining robust technical foundations with disciplined governance and stakeholder engagement, leaders can convert dose monitoring from a compliance item into a sustainable driver of patient safety and operational efficiency.

Research methodology describing a rigorous mixed methods approach that combines stakeholder interviews device audits regulatory review and technology validation protocols

A rigorous mixed-methods research approach underpins credible insights into radiation dose monitoring, blending qualitative stakeholder engagement with technical and regulatory analyses. Primary inputs include structured interviews with clinical leaders, medical physicists, radiology technologists, and procurement officers to capture operational realities, adoption barriers, and desired solution attributes. These conversations are complemented by device and workflow audits that observe data capture points, integration touchpoints, and opportunities for protocol harmonization.

Secondary analysis involves a careful review of regulatory guidance, clinical practice recommendations, and standards for dosimetry and reporting to ensure interpretations reflect current obligations and best practices. Technology verification protocols assess interoperability, data fidelity, and analytic reproducibility under representative clinical conditions. Where possible, cross-site comparisons of implementation pathways and service models are synthesized to surface replicable practices and common pitfalls.

Throughout the process, data governance and ethical considerations guide the collection and use of sensitive clinical information, with anonymization and secure handling protocols applied consistently. Triangulating qualitative insights with technical validation and regulatory context provides a multidimensional view of both the opportunities and constraints facing dose monitoring initiatives.

Conclusion synthesizing strategic takeaways and practical implications for stakeholders aiming to enhance patient safety workflow efficiency and technology integration

The synthesis of technical, clinical, and commercial perspectives reveals a clear imperative: radiation dose monitoring must evolve from isolated compliance mechanisms into integrated clinical intelligence that supports safer, more efficient care. Technological advances in analytics and cloud infrastructure make this transition feasible, yet success depends on deliberate attention to interoperability, governance, and evidence generation. Organizations that prioritize modular architectures, flexible commercial models, and robust service partnerships will be better equipped to sustain capability over time.

Moreover, regional and procurement pressures have underscored the importance of resilient supply strategies and lifecycle planning. Adopting retrofit and software-first pathways can preserve clinical capability while mitigating capital and supply chain risks. Finally, the most impactful implementations are those that align technical functionality with clinician workflows and organizational quality objectives, thereby converting dose monitoring into a measurable contributor to patient safety and operational improvement.

In short, the opportunity lies not merely in deploying new tools but in embedding them into continuous improvement systems that drive accountable, evidence-based change across imaging and interventional services.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radiation Dose Monitoring Market, by Product Type

  • 8.1. Equipment
    • 8.1.1. Fixed Equipment
    • 8.1.2. Portable Equipment
  • 8.2. Services
    • 8.2.1. Consulting Services
    • 8.2.2. Maintenance Services

9. Radiation Dose Monitoring Market, by Application

  • 9.1. Diagnostic Imaging
    • 9.1.1. Computed Tomography
    • 9.1.2. Magnetic Resonance Imaging
    • 9.1.3. Ultrasound
    • 9.1.4. X Ray
  • 9.2. Interventional Radiology
    • 9.2.1. Cardiac Intervention
    • 9.2.2. Neuro Intervention
    • 9.2.3. Vascular Intervention
  • 9.3. Nuclear Medicine
    • 9.3.1. Positron Emission Tomography
    • 9.3.2. Single Photon Emission Computed Tomography
  • 9.4. Radiotherapy
    • 9.4.1. Brachytherapy
    • 9.4.2. External Beam Radiotherapy

10. Radiation Dose Monitoring Market, by End User

  • 10.1. Academic Institutes
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Hospitals

11. Radiation Dose Monitoring Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Radiation Dose Monitoring Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Radiation Dose Monitoring Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Radiation Dose Monitoring Market

15. China Radiation Dose Monitoring Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Agfa-Gevaert Group NV
  • 16.6. Bayer AG
  • 16.7. Bracco Imaging S.p.A.
  • 16.8. Canon Medical Systems Corporation
  • 16.9. Fluke Biomedical
  • 16.10. FUJIFILM Holdings Corporation
  • 16.11. GE HealthCare Technologies Inc.
  • 16.12. Guerbet SA
  • 16.13. Koninklijke Philips N.V.
  • 16.14. Landauer, Inc.
  • 16.15. Ludlum Measurements, Inc.
  • 16.16. Medtronic plc
  • 16.17. Mirion Technologies, Inc.
  • 16.18. Novarad Corporation
  • 16.19. PACSHealth, LLC
  • 16.20. Qaelum NV
  • 16.21. Radiation Detection Company (RADEC)
  • 16.22. Sectra AB
  • 16.23. Siemens Healthineers AG
  • 16.24. Thermo Fisher Scientific Inc.
  • 16.25. Unfors Raysafe AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIATION DOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RADIATION DOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY FIXED EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY FIXED EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY FIXED EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PORTABLE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PORTABLE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY PORTABLE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CARDIAC INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CARDIAC INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CARDIAC INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NEURO INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NEURO INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NEURO INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY VASCULAR INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY VASCULAR INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY VASCULAR INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY BRACHYTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY BRACHYTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 181. GCC RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 182. GCC RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 184. GCC RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. G7 RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. G7 RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 211. G7 RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. G7 RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. G7 RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 214. G7 RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 217. G7 RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 221. NATO RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 222. NATO RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. NATO RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 224. NATO RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 227. NATO RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL RADIATION DOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA RADIATION DOSE MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY NUCLEAR MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY RADIOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA RADIATION DOSE MONITORING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)